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INTRODUCTION:  It  has been  reported  in the  literature  that  upper  gastrointestinal  malignancies  after
bariatric  surgery  are  mostly  gastro-esophageal,  although  it is  not  clear whether  bariatric  surgery  repre-
sents a risk  factor  for  the  development  of  esophageal  and/or  gastric  cancer.  We  report  a case  of  a  de  novo
gastric adenocarcinoma  occurring  in  a transplant  patient  1 year  after  a laparoscopic  sleeve  gastrectomy.
PRESENTATION  OF  CASE:  A  44  year-old  woman  with  a BMI of  38  kg/m2, hypertension,  type 1 diabetes
mellitus,  multiple  malignancies  and a  pancreas  transplant  underwent  laparoscopic  sleeve  gastrectomy.
The  patient  presented  with  intense  dysphagias  during  the  follow  up.  Studies  were  performed  and  the
diagnoses  of  grade  2/3  adenocarcinoma  were  made.  The  patient  underwent  a robotic  assisted  total  gas-
trectomy  with  a roux-en-y  intracorporeal  esophagojejunostomy.  The  procedure  resulted  in multiple
metastasic  lymph  nodes,  focal  and  transmural  invasions  to  multiple  organs  with  a tumor  free  margin
resection.  The  patient  presented  with  a postoperative  pleural  effusion,  with  no further  complications.
DISCUSSION:  The  diagnosis  of  gastroesophageal  cancer  after  bariatric  surgery  is usually  late  since these
patients  have  common  upper  gastrointestinal  symptoms  related  to  the procedure  that  could  delay  the
diagnosis.  De novo  gastric  cancer  after  sleeve  gastrectomy  has  only  been  reported  in  one  instance,  in
contrast  with  other  bariatric  surgery  procedures.
CONCLUSIONS:  No  direct  relation  has  been  established  between  sleeve  gastrectomy  and  the development
of gastric  cancer.  Robotic  procedures  allow  for complex  multiorgan  resections,  while  preserving  the
beneﬁts  of  minimally  invasive  surgery.
© 2016  Published  by Elsevier  Ltd.  on  behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open  access  article
he CCunder  t
. Introduction
The relationship between a high body mass index (BMI) and
alignancies has been well established as obesity is associated with
n increased susceptibility to gastric and esophageal adenocarci-
oma [1–3]. It is not clear whether bariatric surgery may  represent a
isk factor for the development of esophageal and/or gastric cancer
4]. Sleeve gastrectomy (SG) has become one of the most popu-
ar surgical procedures for weight loss in obese patients due to its
afety, technical simplicity, resolution of co-morbidities and excep-
ional weight loss outcomes [5]. In the past 20 years there have been
ew studies reporting malignancies after bariatric surgery [3,4],
ith only 2 reported cases of esophago-gastric adenocarcinoma
fter sleeve gastrectomy [6,7].
∗ Corresponding author at: University of Illinois Hospital and Health Sci-
nce System, 840 South Wood Street 435 E, Chicago, IL 60612, United States.
ax:  +1 312 355 1987.
E-mail address: mmasrur@uic.edu (M.  Masrur).
ttp://dx.doi.org/10.1016/j.ijscr.2015.12.045
210-2612/© 2016 Published by Elsevier Ltd. on behalf of IJS Publishing Group Ltd. This 
rg/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The aim of this study is to report a case of de novo gastric ade-
nocarcinoma occurring in a transplant patient 1 year after sleeve
gastrectomy.
2. Case report
A 44 year-old woman  with a BMI  of 38 kg/m2 and a past medical
hisroty of hypertension, type 1 diabetes mellitus, hyperlipidemia,
bipolar disorder, sleep apnea, vaginal dysplasia, grade III vulvar
intraepithelial neoplasia, anal condilomatosis and of heavy tobacco
use; past surgical history of a pancreas transplant performed 4
years prior underwent laparoscopic sleeve gastrectomy (LSG). As
part of the work up, a swallow contrast study showed grade 1
esophagitis. The patient underwent LSG and an incidental hiatal
hernia was  repaired without complications. Specimen was neg-
ative for histopathology changes and negative for Helicobacter
pylori (pathology report: fundic type gastric mucosa and muscularis
propia with negative for signiﬁcant histopathologic changes).Patient presented with an uneventful follow-up at 1, 3, 6, and 8
months. At the 8 month follow-up %EBWL was 52%, also presented
with mild dysphagia to solids; an esophagogastroduodenoscopy
(EGD) was performed that reported inﬂammation of the gastric and
is an open access article under the CC BY-NC-ND license (http://creativecommons.
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Fig. 2. Trocar placement.ig. 1. Esophagus ﬂuoroscopy identifying gastric stricture (EGJ = Esophago-gastric
unction).
sophageal mucosa with no strictures. The patient was  discharged
ith proton pump inhibitor medication.
The patient returned to the hospital 3 weeks after with wors-
ning symptomatology, extreme dysphagia to solids and liquid
ntolerance. A second EGD and ﬂuoroscopy study were performed
hat showed a tight stricture, 10 cm from the gastroesophageal
unction (Fig. 1). Endoscopic dilation of the area and random
iopsies were performed. The pathology examination showed
oderately differentiated grade 2/3 adenocarcinoma and positive
nmunostain to HER2/NEU. A CT scan was performed for stratiﬁ-
ation that showed a thickened gastric sleeve wall with no other
etastatic nodules.
The patient underwent a minimally invasive approach, a 12 mm
rocar for the robotic camera was placed left to the umbilicus with
id  clavicle line, 8 mm  robotic trocar for the 1st arm was  placed
ubcostal following the left anterior axilar line, the 2nd and 3rd arm
rocars was placed in the subcostal area following the right mid
lavicular line and anterior axilary line, respectively, for the assis-
ant port the trocar was placed 5 cm medially of the 2nd arm, the
obot cart was docked from the head of the patient (Fig. 2). During
he operation a rigid stomach was found with dysplastic changes
n the gastric esophageal junction and thickening of the distal
sophagus (Fig. 3). The tumor was invading transmurally into the
erigastric adipose tissue and focally into the visceral peritoneum,
ancreatic stromal tissue, transverse colon and distal esophagus.
obot-assisted total gastrectomy with a Roux-en-Y intracorporeal
sophagojejunostomy, omentectomy, distal esophagectomy, dis-
al splenopancretectomy, tangential colon resection with a feeding
ejunostomy were all performed (Figs. 4 A–D and 5 A–D).
The histologic examination revealed poorly differentiated and
iffused type grade 3 gastric adenocarcinoma (pT4b, pN3a). The
esection margins were tumor free, while there were metastasis to
/2 lesser curvature lymph nodes, 2/2 perigastric lymph nodes, 1/1
plenic lymph nodes and 4/4 esophageal pedicle lymph nodes.Fig. 3. Intraoperative view of the gastric sleeve.
The operation was  completed within 360 min, with an approx-
imate blood loss of 200 ml.  The patient was transferred to the
surgical intensive care unit (SICU) for monitoring. The patient pre-
sented with a postoperative bibasal pleural effusion while in the
SICU requiring chest tube drainage, with no further complications.
The patient was  tolerating diet and was  discharge on postopera-
tive day 14th. Patient is currently doing well at 8 month follow-up,
with no sign of recurrences. Patient completed chemotherapy using
Herceptin.
3. Discussion
Gastroesophageal cancer following a bariatric procedure has
been previously reported in the literature [3–6]. The diagnosis of
gastroesophageal cancer following bariatric surgery is usually late
since these patients present with common upper gastrointestinal
symptoms related to the procedure such as oral intolerance, nausea
and vomiting.
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Fig. 4. Intraoperative view of transection at 1st portion of duodenum (A), transverse colon invasion (B), transection of distal pancreas (C) and M-block disection of distal
pancreas (D).
Fig. 5. Intraoperative view of mediastinal dissection of distal esophagus (A), transection of distal esophagus (B), jejuno-jejunostomy (C) and esophago-jejunostomy with
circular  stapler (D).
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To our knowledge this is the third reported case of de
ovo gastric cancer after LSG; nonetheless, it appears to be the
ariatric procedure least related to cancer when compared with
ther bariatric procedures. Previous reports showed a case of
denocarcinoma of the lower esophageal sphincter (T2N1Mx) diag-
osed 4 month after SG in a patient that did not undergo a
reoperative EGD evaluation [5] and a second case of signet-ring
ell adenocarcinoma of the body, antrum and pylorus of the stom-
ch with lymph nodes metastasis (T4N1Mx) diagnosed 4 years after
G [6].
In our case, the cancer was aggressive and locally invasive,
nvolving continuous organs and lymph nodes. The patient had
everal known risk factors for cancer. She was morbidly obese, a
eavy cigarette smoker, immunosuppressed post pancreatic trans-
lant and presented other neoplasm (grade III vulvar intraepithelial
eoplasia, anal condilomatosis). In consideration of the patient’s
ransplant history and immune suppression therapy, laparoscopic
leeve gastrectomy was the procedure chosen for the metabolic and
estrictive changes, avoiding the malabsortion component of alter-
ative procedures that can jeopardize the outcome of the transplant
y adjusting the immunosuppressive medication [8].
The increase in minimally invasive surgical skills provided by
he robotic system allows for complex multiorgan resections while
reserving the beneﬁts of the minimally invasive surgical approach.
Despite the reported occurrences of upper gastrointestinal can-
er following bariatric surgery, the incidence continues to be very
ow to suggest implementing a speciﬁc screening prior to SG.
lthough previous reports suggest performing EGD’s routinely [9],
here is not enough data to support the need for further screening.
n our practice EGD’s are not performed routinely, unless patients
resent with suspicious symptoms. Patients do undergo routinely
pper GI swallow test pre-operatively with the aim of detecting
symptomatic hiatal hernias.
. Conclusion
No direct relation has been established between sleeve gas-
rectomy and the development of gastric cancer. We  believe it is
mportant to report this occurrence to better understand the nature
r relation of bariatric surgery and upper gastrointestinal cancer.
urther studies are needed in order to draw deﬁnitive conclusions
egarding screening and the role of the preoperative EGD.
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